Investigation of the effects of 50 Hz electromagnetic field on the lifespan of the red blood cells in vitro by Elmas, Sinem et al.
ISSN 2449-8955 
European Journal  
of Biological Research 
Research Article 
 
European Journal of Biological Research 2021; 11(2): 177-188 
DOI: http://dx.doi.org/10.5281/zenodo.4447339  
Investigation of the effects of 50 Hz electromagnetic field 
on the lifespan of the red blood cells in vitro 
Sinem Elmas 1, Onur Elmas 2*, Ahmet Zeybek 1 
1 Mugla Sitki Kocman University, Faculty of Sciences, Department of Biology, Mugla, Turkey 
2 Mugla Sitki Kocman University, Faculty of Medicine, Department of Physiology, Mugla, Turkey 
* Corresponding author: Tel: + 90 507 9468430; Fax: + 90 252 2115155; E-mail: onurelmas@outlook.com 
Received: 17 September 2020; Revised submission: 13 January 2021; Accepted: 18 January 2021 
 
http://www.jbrodka.com/index.php/ejbr 
Copyright: © The Author(s) 2021. Licensee Joanna Bródka, Poland. This article is an open access article distributed under the 
terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/) 
ABSTRACT: In recent years, studies have indicated that electromagnetic fields (EMFs) may have harmful 
effects on human health. The effects on human health of the 50 Hz extremely low frequency EMF (ELF-
EMF), which is often used in daily life, are still controversial. In our study, we investigated the in vitro effects 
of 50 Hz ELF-EMF on the lifespan of erythrocytes, which have no nucleus and organelles, and are therefore 
relatively more sensitive compared to other cells in the body to any harmful effect that may come from 
outside. Whole blood obtained from healthy volunteers was exposed to 50 Hz, 0.3 mT ELF-EMF over 35 
days. After this time, erythrocytes (red blood cell, RBC) counts in blood, hematocrit (HCT) value, main 
corpuscular volume (MCV), and erythrocyte osmotic fragility (EOF), an indicator of aging, were examined. 
At the end of 35 days, RBC and HCT were decreased while MCV and EOF were increased in the blood 
samples of both the EMF-exposed group and the non-exposed group. However, while there were no 
statistically significant changes in terms of RBC counts, and HCT between the two groups, it was observed 
that MCV and EOF increased significantly less in the EMF-exposed group compared to the non-exposed 
group. These results suggest that 50 Hz ELF-EMF exposure does not affect the lifespan of erythrocytes in 
vitro, but it may extend erythrocytes’ lifecycles due to a reduction in osmotic fragility of the erythrocytes in in 
vivo conditions. 
Keywords: Red blood cell; Erythrocyte; Osmotic fragility; Electromagnetic field; ELF-EMF. 
1. INTRODUCTION 
Since the use of electrical devices is increasing day by day, living beings that are close to them are 
affected by the electromagnetic field (EMF) while these electromagnetic devices run. Since the powerline 
frequency is 50 Hz (60 Hz in some countries), these beings are mostly exposed to EMFs in this frequency 
band. In many previous studies, it was mentioned that the devices that run on powerline frequency may harm 
living beings with the EMFs they create. Short-term EMF exposure studies on nerve and heart tissues, which 
can be stimulated by EMFs, it was stated that 50 Hz extremely low exposure EMF (ELF-EMF) affects the 
electrical activity of the brain and decreases the speed of neural transmission, as well as the heart rate [1-6]. In 
contrast, the structural functions of the tissues have mainly examined in long-term exposure studies; such 
studies have shown that ELF-EMF may cause childhood cancers, developmental disorders, cancers in adults, 
Elmas et al.   Effects of 50 Hz electromagnetic field on the red blood cells in vitro 178 
 
European Journal of Biological Research 2021; 11(2): 177-188 
reproductive dysfunction, cardiovascular disorders, depression, suicide, neurobehavioral effects, 
immunological modifications, and neurodegenerative diseases like Alzheimer’s disease and amyotrophic 
lateral sclerosis [7, 8]. However, the results obtained from both short-term and long-term exposure studies 
have not been confirmed in subsequent studies [9-13]. The reason for the differences between the results of 
the studies may have occurred because the changes caused by the exposure are compensated by the beings’ 
internal systems. This idea suggests that the 50 Hz ELF-EMF exposure may have a greater effect on cells with 
lower compensation ability. 
Erythrocytes are blood tissue cells that have the main function of carrying oxygen to tissues. They 
contain a protein called hemoglobin that has iron in its structure and has a lifespan of 100-120 days in the 
circulation [14]. In 1 ml of blood, although the amounts are different in men and women, there are 4.5-5.5 
million erythrocytes on average. In contrast to the other cells, erythrocytes do not engage in DNA replication 
and protein synthesis, since they do not contain a nucleus [15]. Erythrocytes should contain with their own 
intracellular enzyme proteins after they develop until they die. For this reason, when erythrocytes are 
compared to other cells, the ability to compensate for the probable response that may occur because of EMF 
exposure is quite low when compared to that of the other cells in the organism. 
Because erythrocytes cannot defend themselves against harmful exposures sufficiently, it is thought 
that exposure studies carried out in vitro on erythrocytes will represent a good model to research the cellular 
effects of ELF-EMF. There is no exposure study based on this idea in the literature. For this reason, it was 
planned in this study to examine the effect of 50 Hz ELF-EMF on the lifespan of erythrocyte cells in in vitro 
conditions. 
2. MATERIALS AND METHODS 
2.1. Ethical approval 
Approval was received from the Muğla Sıtkı Koçman University Faculty of Medicine Clinical Studies 
Ethics Committee. 
2.2. Setup 
An Ndustrio (Ekofan, İzmir, Turkey) brand blood storage cabinet was used. Two bobbins (Pasco EM-
6724, Roseville, CA, US) with 500 coils with inner diameters of 18.6 cm and external diameters of 22.1 cm 
were placed parallel to each other and spaced 21 cm apart, as shown in Fig. 1. Only a glass shelf with 4 mm 
thickness was placed between two bobbins. These two bobbins were fed in series with a waveform generator 
with an amplifier (Pasco PI-8127, Roseville, CA, USA); in this way, a Helmholtz coil setup was built. In the 
Helmholtz coil system, it is assumed that the magnetic flux between two bobbins is parallel and homogeneous 
[16]. The cables that feed the bobbins are fed through air-tight holes in the blood storage cabinet and the 
device that generates the waveform is placed outside of the incubator. A container in which the blood samples 
are kept is placed in the middle of the bobbins, as illustrated in Fig. 1.  
2.3. Electromagnetic field 
The frequency (50 Hz), waveform (sinus), and voltage (10 V; maximum output voltage of the device) 
of the electricity to be generated was is set on the device. The frequency and the waveform of the EMF 
generated between the bobbins was tested with a Powerlab 16/35 (Adinstruments, New South Wales, 
Australia) data-recording device, and the magnetic flux density of the EMF was tested with a Chauvin Arnoux 
Elmas et al.   Effects of 50 Hz electromagnetic field on the red blood cells in vitro 179 
 
European Journal of Biological Research 2021; 11(2): 177-188 
CA42 (Paris, France) 0-400 kHz Gaussmeter. The current passing through the bobbins at 10 V was 0.09 A. 
The magnetic flux density generated in the middle of the bobbins in this current was measured as 0.3 mT. The 
magnetic flux density between the bobbins when the power supply was off was not higher than 1 µTesla and 
the electric field intensity was not higher than 1 V/m. 
 
 
Figure 1. Helmholtz coil setup. Two bobbins (A) are placed in parallel and connected in series electrically. A container 
(B) containing blood samples (C) is placed on a plastic glass in the middle of two bobbins. 
 
2.4. Temperature control of the blood cabinet 
The temperature of the cabinet was set as +4°C. This temperature was monitored during the 
experiment with a temperature probe (MLT12, Adinstruments, New South Wales, Australia) and a Powerlab 
16/35 (Adinstruments, New South Wales, Australia) data-recording device. 
2.5. Source of the erythrocytes 
All blood products were obtained from 60 male volunteers who applied to the “Ministry of Health 
Muğla Sıtkı Koçman University Training and Research Hospital Transfusion Center” (Muğla, Turkey) as 
donors for “Complete Blood Donation” and whose blood types were “O Rh (+)”. The criteria under the topic 
title of “Blood Donor Selection” defined in the “National Blood and Blood Products Guide” were used in the 
selection of donors (Table 1) [17].  
2.6. Receiving the blood from the donor and transferring it to the laboratory 
Complete blood was obtained by entering the collecting vein in the forearm through a cannula. 450 ml 
of blood was collected in a PVC blood collection bag (Kansuk, İstanbul, Turkey) with a leukocyte filter. There 
was 63 ml of standard citrate-phosphate-dextrose-adenine (CPDA-1) solution in the blood collection bag. Two 
blood samples with 1 ml of blood in average were taken from each of the blood collection bags and the 
sample numbers on them were recorded. Afterwards, these blood samples were placed in blood storage 
cabinet at +4°C. The duration between the time blood was taken from the donor and the time the experiment 
began was not more than 24 hours and strict attention was paid to keeping the blood at +4°C during blood 
transfer. 
Elmas et al.   Effects of 50 Hz electromagnetic field on the red blood cells in vitro 180 
 
European Journal of Biological Research 2021; 11(2): 177-188 
Table 1. Criteria under the topic title of “Blood Donor Selection” defined in the “National Blood and Blood Products 
Guide” (Ministry of Health, 2011). 
1. Age range Must be 19–66 years 
2. Donation frequency Should be longer than 90 days for men and 120 days for women 
3. Pulse Should be regular and between 50 and 100 in a minute 
4. Body temperature Should not be above 37.5°C 
5. Body weight Must be at least 50 kg 
6. Blood pressure 
Systolic pressure should be 90–180 mm Hg and diastolic pressure should be 60–
100 mm Hg 
7. Hemoglobin level Should be 13.5–18.0 g/dl for men and 12.5–16.5 g/dl for women 
8. Medical history Should not have a known disease 
9. Alcohol Should not consume alcohol 12 hours in advance 
10. Drug use 
Should not use drugs before donation (rejection is applied according to the 
appropriate time period according to the pharmacokinetics qualities of the drug. 
For example, the period is 5 days for aspirin and piroxicam) 
11. Blood volume to take 
Volume of the blood donation should be 450 mL ± 10% except for the 
anticoagulant solution 
 
2.7. Formation of the groups 
Two experimental groups are formed, namely the EMF group (n=30) and the control group (n=30). As 
the experiment groups were carried out, sample selections for each group were realized at random.  
2.8. Procedure 
For the EMF group, laboratory tests were studied from one of the pair of blood samples belonging to 
the donors. The second blood sample was placed in the EMF setup, as shown in Fig. 1. According to the 
“National Blood and Blood Products Guide,” the lifetime of complete blood that contains CPDA-1 for 
transfusion is accepted as 35 days [17]. For this reason, blood samples were left under EMF exposure for 35 
days in total. At the end of the exposure, laboratory tests from all blood samples were studied again. The same 
procedure was applied using the same setup for the control group blood. However, the waveform generator 
was closed during the incubation of control blood and no EMF was generated in the setup.  
2.9. Laboratory analyses 
Laboratory analyses were carried out on the bloods both before the experiment started and after they 
were left in the exposure setup for 35 days. 
2.9.1. Cell count 
An erythrocyte dilution pipette (Marienfeld-Superior, Königshofen, Germany) was filled with blood to 
the 0.5 line. Then, it was filled with Hayem solution up to the 101 line (a mixture of 0.5 g of mercury 
chloride, 5 g of sodium sulfate, 1 g of sodium chloride, and 200 ml of distilled water). In this way, the blood 
was diluted 200 times. Afterwards, a drop of diluted blood was dripped onto a counting chamber (Thoma, 
Marienfeld-Superior, Königshofen, Germany) covered with a lamella. The used counting chamber consisted 
of a chamber with sides of 1 mm and a length of 0.1 mm. The total volume of this chamber was 0.1 mm3 (1 
mm x 1 mm x 0.1 mm). The large square with sides of 1 mm was divided into 16 squares with three 
longitudinal and transverse lines. When three lines were excluded, the side of each of these squares was 0.2 
mm and the volume was 0.004 mm3 (0.2 x 0.2 x 0.1 mm). The cells in counting chamber are counted with the 
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help of an optical microscope (Eclipse Ci-L, Nikon Instruments, Tokyo, Japan) at 400x magnification. For the 
determination of erythrocyte number, four squares at the corners of the 16 squares and one of the squares in 
the middle of the chamber were counted. The total volume through which the cell count was realized was 5 
(the number of counted squares) x 0.02 = 0.1 mm3. Consequently, a total cell number was found with the 
formula of total cell number = counted cell number x 200 (dilution coefficient) / 0.02 mm3 (total volume of 
the five counted squares). In the counting process, leukocytes and thrombocytes, which were not filtered and 
infrequently observed, were not taken into consideration. 
2.9.2. Determination of hematocrit (HCT) 
HCT provides the rate that the total erythrocyte volume covers in the total blood volume, and it is 
calculated as follows: 
 
A heparin-containing capillary tube (Nris, Vitrex, Herlev, Denmark) was filled to the 3/4 of the tube 
with blood to be analyzed. Then, one tip of the tube was closed with glass putty. The capillary tubes were 
placed in an HCT centrifuge (MicroCL 17, Thermo Fisher Scientific, Osterode, Germany). Then, these tubes 
were centrifuged for 5 minutes at 12,500 rpm. Afterwards, the rate of erythrocyte volume / total blood volume 
in the tubes was found using an HCT scale. 
2.9.3. Main corpuscular volume (MCV) 
MCV shows the average volume of erythrocytes in a sample. This value is calculated as follows: 
 
2.9.4. Osmotic fragility test 
For each osmotic fragility test, a total of six 5 ml tubes were used with the following contents prepared 
before the study: 1) 0.9% NaCl, 2) 0.6% NaCl, 3) 0.5% NaCl, 4) 0.4% NaCl, 5) 0.3% NaCl, and 6) distilled 
water. Then, 0.05 ml of blood was pipetted in these tubes. There was a waiting period for 20 minutes and then 
the tubes were placed in a centrifuge (Nüve NF800, Istanbul, Turkey) and centrifuged for 5 minutes at 3,000 
rpm. Following this, liquid at a volume of 0.1 ml was obtained from the remaining supernatant on the tubes 
and absorbance was read at 540 nm with a spectrophotometer (Spectramax i3, Molecular Devices, Sunnyvale, 
CA, USA). In the absorbance reading, solutions that did not include pipetted blood were used as a blind 
sample. Then, Tube 1 (0.9% NaCl solution) and Tube 6 (distilled water) were considered as the negative (0% 
hemolysis) and positive (100% hemolysis) controls, respectively. The percentages of the hemolysis values in 
Tubes 2, 3, 4, and 5 were found by comparing the absorbance of the Tubes 1 and 6. In addition, CH20, CH50, 
and CH80 (sodium solution in which 20%, 50%, and 80% of total erythrocytes were hemolyzed) values are 
found for each blood sample by the acquiring regression formula from the hemolysis values.  
2.10. Statistical analysis 
Before the study, the sample size was calculated with GraphPad StatMate 2.0 (GraphPad Software, San 
Diego, CA, USA; Windows 8.1) software to prevent Type II error (false negative). The following setup was 
used in the calculation of the sample size: alpha 0.05, beta 0.2, and power 0.8. Post hoc power analysis was 
carried out with the parameters acquired after the study using the same software and setup. Whether all values 
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acquired from the study were compatible with normal distribution was evaluated using the D’Agostino–
Pearson omnibus normality test and the Shapiro–Wilk normality test. In the study, the percentage change at 
the end of the 35th day was determined using the following formula: 
  
Whether there was a statistical difference between % change value parameters belonging to the control 
and EMA groups was evaluated using the Mann-Whitney U test. In all cases, the alpha value was selected as 
0.05, and a p-value below 0.05 was accepted as significant; and p-value below 0.0001 was accepted as very 
significant.  
3. RESULTS 
The erythrocyte counts, the HCT and the MCV values, and statistical results are shown in Table 2.  
 
Table 2. Hemogram values and statistical comparison between groups. 
 Control Group (n=30) EMF Group (n=30) P value  
of the % 
changes  1
st day 35th day % changes 1st day 35th day % changes 
RBC count 
(x106/mm3) 
4.69 ± 0.62 4.57 ± 0.59 -1.99 ± 0.18 4.70 ± 0.51 4.61 ± 0.56 -1.72 ± 0.24 0.40 
Hematocrit (%) 43.6 ± 5.80 42.5 ± 5.46 -2.82 ± 0.40 44.5 ± 4.93 43.6 ± 5.01 -2.67 ± 0.38 0.52 
Main corpuscular 
volume (fL) 
92.6 ± 7.13 93.4 ± 7.01 1.06 ± 0.14 92.6 ± 6.48 92.8 ± 6.64 0.95 ± 0.12 0.0068** 
 
3.1. Erythrocyte count analysis 
 The erythrocyte count in cubic millimeters decreased at a rate of 1.99±0.18% in the control group and 
1.72±0.24% in the EMF group at the end of the 35-day period. There was no statistically significant 
difference between the % changes in the two groups in terms of erythrocyte counts (p=0.40).  
3.2. HCT analysis 
 The HCT value decreased at a rate of 2.82±0.40% in the control group and 2.67±0.38% in the EMF 
group at the end of the 35-day period. There was no statistically significant difference between the % changes 
in the two groups in terms of HCT (p=0.52). 
3.3. MCV analysis 
 The MCV value decreased at a rate of 1.06±0.14% in the control group and 0.95±0.12% in the EMF 
group at the end of the 35-day period. MCV increased less in the EMF group compared to the control group; a 
highly statistically significant difference was found between % changes in the two groups (p=0.0068). 
3.4. Osmotic fragility analysis 
 From the osmotic fragility tests, the % hemolysis values of erythrocytes in 0.9%, 0.6%, 0.5%, 0.4%, 
0.3%, and 0.0% NaCl solutions are shown in Table 3 and the osmotic fragility curves drawn by means of 
these values is given in Fig. 2a and 2b. At the end of 35-day period, a shift to the right (i.e., an increase in 
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osmotic fragilities) was observed in the osmotic fragility curves of erythrocytes belonging to both the control 




Figure 2. a) Osmotic fragility curve of control group, b) Osmotic fragility curve of EMA group. 
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Table 3. Osmotic fragility tests result and statistical comparison between groups. CH20, CH50 and CH80 show the 
sodium solution in which 20%, 50%, and 80% of total erythrocytes are hemolyzed. 
  
Control Group (n=30) EMF Group (n=30) P value of the 




0.9% NaCl 0 0 0 0 0 0 >99 
0.6% NaCl 4.28 ± 0.87 5.11 ± 1.22 0.22 ± 0.15 4.15 ± 0.81 4.39 ± 1.01 0.03 ± 0.10 < 0.0001*** 
0.5% NaCl 37.3 ± 5.15 51.5 ± 8.95 0.39 ± 0.07 32.6 ± 5.59 44.8 ± 6.68 0.36 ± 0.05 0.033* 
0.4% NaCl 88.2 ± 15.1 90.1 ± 16.4 0.18 ± 0.07 90.7 ± 16.3 91.8 ± 17.2 0.13 ± 0.08 0.38 
0.3% NaCl 95.9 ± 9.16 99.5 ± 8.45 0.08 ± 0.07 95.5 ± 9.72 99.0 ± 8.54 0.06 ± 0.44 0.88 





CH20 0.54 ± 0.03 0.57 ± 0.04 5.62 ± 1.56 0.53 ± 0.03 0.55 ± 0.03 3.74 ± 1.05 0.0019** 
CH50 0.47 ± 0.03 0.50 ± 0.03 6.44 ± 1.84 0.47 ± 0.03 0.48 ± 0.04 2.74 ± 1.76 0.0004** 
CH80 0.41 ± 0.03 0.43 ± 0.05 4.97 ± 1.19 0.41 ± 0.04 0.42 ± 0.05 3.23 ± 1.16 0.036* 
 
 According to the data acquired, it was seen that erythrocyte fragility in 0.6% NaCl solution increased 
at a rate of 0.22±0.15% in the control group and 0.03±0.10% in the EMF group at the end of the 35-day 
period. Erythrocyte fragility in 0.6% NaCl solution increased less in the EMF group; a highly statistically 
significant difference was found between the % changes in the two groups (p<0.0001). It was observed that 
erythrocyte fragility in the 0.5% NaCl solution increased at a rate of 0.39±0.07% in the control group and 
0.36±0.05 % in the EMF group. As in the 0.6% NaCl solution, erythrocyte fragility in 0.5% NaCl solution 
increased less in the EMF group, % changes in the two groups were statistically significant (p=0.033). At the 
end of the 35-day period, the erythrocyte osmotic fragility increased in both the control group and EMF group 
in 0.4% and 0.3% NaCl solutions. However, there was no statistical significance between the two groups in 
terms of changes in this increase (p=0.38, p=0.88, respectively). 
 CH20, CH50, and CH80 (NaCl solutions in which 20%, 50%, and 80% of total erythrocytes were 
hemolyzed) values calculated with regression formula acquired by using % hemolysis values are shown in 
Table 3. At the end of the 35th day, it was found that CH20 increased at rate of 5.62±1.56% in the control 
group and 3.74±1.05% in the EMF group, CH50 increased at a rate of 6.44±1.84% in the control group and 
2.74±1.76% in the EMF group, and CH80 value increases at a rate of 4.97±1.19% in the control group and 
3.23±1.16% in the EMF group. The CH20, CH50, and CH80 values increased less in the EMF group 
compared to the control group and a statistically significant difference was observed between the % changes 
in the two groups (p=0.0019, p=0.0004, and p=0.036, respectively).  
4. DISCUSSION 
Our aim in the study was to examine possible effect of 50 Hz ELF-EMF exposure on the erythrocyte 
lifespan under in vitro conditions. A limited number of studies have examined the effects of EMF exposure at 
different frequencies and intensities on blood parameters in the literature; moreover, there has been no 
consensus on the acquired results. Dasdag et al. stated that 50 Hz ELF-EMF increases hematocrit values but 
does not affect other parameters [18]. Çakır et al. did not encounter any kind of change in erythrocyte number 
and HCT value when they applied ELF-EMF exposure to rats [19]. Bonhomme-Faivre et al. observed a 
decrease in the erythrocyte number and HCT value on the 20th day of ELF-EMF exposure, but they did not 
reach the same conclusion for longer exposures [20]. All of these studies were in vivo studies. The research 
carried out by Bonhomme-Faivre et al. suggests to us that the results caused by an exposure to EMF that can 
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effect erythrocytes might be compensated for in time by an increase or decrease in the erythrocyte production 
speed by living organisms. For this reason, if there is an influence caused by EMF in the erythrocyte lifespan, 
we think that it can only be shown through an in vitro study. 
According to the findings acquired from this study, over 35 days of 50 Hz ELF-EMF exposure, there 
were no statistically significant changes in terms of the change rates of RBC counts, and HCT between the 
two groups. It was observed that MCV and EOF in the EMF-exposed group showed a significantly lower 
reduction compared to the non-exposed group. Since there were no differences in terms of erythrocyte 
number, and in relation to this, in the HCT value at the end of 35 days, we saw that the EMF exposure in the 
dosage we applied did not affect the erythrocyte lifespan under in vitro conditions. In addition, MCV and 
osmotic fragilities of erythrocytes under EMF exposure increased less compared to the control group; 
therefore, we think that EMF in the dosage we applied decreased the forces that affect the erythrocyte 
membrane and cause fragility.  
Since erythrocytes do not contain organelles such as DNA and mitochondria, they do not die by 
apoptotic mechanisms seen in other body cells. Their cause of death is completely related with physical 
forces: As erythrocytes get old, the intracellular antioxidation/oxidation balance deteriorates; as a result of this 
deterioration, oxidation of membrane lipids occurs. As a consequence of oxidation, cell membranes become 
more and more stiff and become more fragile. Thus, the osmotic fragility of the aging cells increases. 
Normally, the erythrocyte diameter is 8 microns in its thickest place, but the diameter of a systematic capillary 
is 5 microns. For this reason, erythrocytes become stuck when they pass through the capillaries and their 
shapes change. Cell membranes of old erythrocytes, especially in places where the vessel diameter is less as 3 
microns, cannot endure the pressure and undergo lysis. In this way, after an erythrocyte is produced in the 
bone marrow, it remains in circulation for around 120 days. According to the study results, it is possible to say 
that since 50 Hz EMF decreases osmotic fragility, it may also slow down aging. If EMF slows down the aging 
of erythrocytes, it would be reasonable to expect erythrocyte number and HCT values in cubic millimeters to 
be higher compared to the non-exposed group. However, we did not observe a significant change in either 
parameter in our study. We think that this was the case because we did not use an in vivo environment in our 
study. Therefore, even if erythrocytes get old and cell membranes become more fragile, since they are not 
exposed to a physical stress, such as passing through capillary vessels, erythrocytes may not die under in vitro 
conditions; this may be why there was no difference between the two groups in terms of the results for cell 
number and HCT. If the blood used in the experiment were to be transfused to another patient later on, it 
would probably have a longer lifespan compared to the blood of the control group, since the blood of the EMF 
group would be less fragile.  
According to the data we acquired from the study, 50 Hz ELF-EMF exposure had the effect of 
retarding erythrocyte aging. We did not encounter any kind of information that presented a probable 
mechanism. It may be that 50 Hz ELF-EMF effects oxidation/antioxidation systems have a direct effect on the 
cell membrane. It has been claimed that ELF-EMF exposure increases oxidative stress in studies carried out 
using serum, lung, nerve, myocardial, and squamous cancer cells[21–27]. Again, in some studies realized 
using brain tissues and muscle tissues, it was claimed that ELF-EMF exposure decreases oxidative stress [28-
30]. In addition, there was no change encountered in terms of oxidative stress in serum and 
pheochromocytoma cells in recent exposure studies [31, 32]. As this makes the clear, the effect of ELF-EMF 
on oxidation/antioxidation systems in the literature is contradictory. We think that the answer to the question 
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regarding how 50 Hz ELF-EMF exposure affects erythrocytes over oxidation/antioxidation systems can be 
elucidated through studies focusing on intracellular biochemical and molecular analysis. 
5. CONCLUSION 
In this study, we observed that 50 Hz ELF-EMF exposure does not affect the lifespan of erythrocytes 
in vitro, but it may extend erythrocytes’ lifecycles due to the reduction of the osmotic fragility of the 
erythrocytes in in vivo conditions. These findings can potentially be used in the future to extend the 
preservation period in environments like blood banks where blood products are stored. In addition, we hope 
that the study results will guide scientists and policymakers who are interested in EMF pollution. 
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